Antibody Drug Conjugate

Antibody-drug conjugates or ADCs are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. By combining the unique targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs, antibody-drug conjugates allow sensitive discrimination between healthy and diseased tissue. This means that, in contrast to traditional chemotherapeutic agents, antibody-drug conjugates target and attack the cancer cell so that healthy cells are less severely affected. The biochemical reaction between the antibody and the target protein (antigen) triggers a signal in the tumor cell, which then absorbs or internalizes the antibody together with the cytotoxin. A stable link between the antibody and cytotoxic (anti-cancer) agent is a crucial aspect of an ADC.

Linkers are based on chemical motifs including disulfides, hydrazones or peptides (cleavable), or thioethers (noncleavable) and control the distribution and delivery of the cytotoxic agent to the target cell. Cleavable and noncleavable types of linkers have been proven to be safe in preclinical and clinical trials.

    Related Conference of Antibody Drug Conjugate

    June 29-July 01, 2017

    8th European Immunology Conference

    Madrid, Spain
    July 03-05, 2017

    9th Asia-Pacific Global Summit on Healthcare & Immunology

    Kuala Lumpur, Malaysia
    July 12-13, 2017

    3rd World Conference on Parasitology & Pathogenesis

    Chicago, Illinois, USA
    September 01-02, 2017

    4th International Conference on Parasitology

    Prague, Czech Republic
    September 11-12, 2017

    7th World Congress on Immunology

    Amsterdam, Netherlands
    November 2-3, 2017

    9th World Congress and Expo on Immunology

    Atlanta, Georgia, USA
    November 02-03, 2017

    9th World Congress on Immunity, Inflammation and Immunotherapies

    Atlanta, Georgia, USA
    November 06-07, 2017

    2nd International Conference on Autoimmunity

    Frankfurt, Germany
    November 08-09, 2017

    3rd Antibodies and Bio Therapeutics Congress & B2B

    Las Vegas, Nevada, USA
    November 13-14, 2017

    5th International Conference on HIV/AIDS, STDs and STIs

    Las Vegas, Nevada, USA
    Dec 14-15, 2017

    World Immunology Congress

    Dubai, UAE
    May 10-12, 2018

    Immunology and Evolution of Infectious Disease

    Frankfurt, Germany
    April 16-17, 2018

    EuroSciCon Conference on StemCell

    Amsterdam, Netherlands
    July 05-07, 2018

    EuroSciCon Conference on Immunology

    Vienna, Austria

    Antibody Drug Conjugate Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in